The transaction accelerates the expiration of biosimilars non-compete restrictions, the company said.

The U.S. health regulator on Friday approved Innoviva's oral antibiotic to treat gonorrhea, a common sexually transmitted infection, offering patients an alternative to an injectable drug that was the ...

Zoliflodacin, which will be marketed under the name Nuzolvence, is the first new drug to uniquely target gonorrhea infections ...

IV iron administration has historically been a “controversial issue” for treatment of iron deficiency anemia during acute infections, but data presented at ASH Annual Meeting and Exposition detailed ...

Treatment with intravenous (IV) iron significantly improved survival and increased hemoglobin levels in patients with ...

Guideline states that prochlorperazine IV and greater occipital nerve blocks must be offered to eligible adults requiring parenteral therapy.

Inebilizumab-cdon is approved for anti-acetylcholine receptor and anti-muscle specific tyrosine kinase antibody–positive generalized myasthenia gravis, based on MINT trial results. Inebilizumab gains ...

Early panretinal photocoagulation plus anti-VEGF for macular edema secondary to retinal vein occlusion offers no benefit over anti-VEGF alone.